Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yigan Qingdu granules plus entecavir for chronic hepatitis B
CTR20160135Phase 2Active
- Sponsor
- Beijing Rongzhiyuan Pharmaceutical Technology
- Start
- May 2016
- Countries
- 1
01
Overview
A Phase 2 trial of Yigan Qingdu Granules in Chronic Hepatitis B (CHB), sponsored by Beijing Rongzhiyuan Pharmaceutical Technology. Started May 2016; status: active.
02
Drugs
Yigan Qingdu Granules
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20160135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160135.